Literature DB >> 521805

Differentiation of the haemagglutinin genes of variant influenza viruses by RNA-RNA hybridization.

A J Hay, J J Skehel, R G Webster.   

Abstract

The genetic compositions of four antigenic variants of A/Memphis/1/71 (H3N2) influenza virus, which were selected by growth in the presence of monoclonal antibodies against the haemagglutinin, were compared. The results indicate that the mutant haemagglutinin genes can be differentiated by polyacrylamide gel electrophoresis of the double stranded RNA hybrids formed between virion RNA and transcripts isolated from infected cells.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 521805     DOI: 10.1099/0022-1317-45-1-245

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  6 in total

1.  Avian influenza from an ecohealth perspective.

Authors:  Les Simms; Martyn Jeggo
Journal:  Ecohealth       Date:  2014-04-24       Impact factor: 3.184

2.  Virulence of La Crosse virus is under polygenic control.

Authors:  R S Janssen; N Nathanson; M J Endres; F Gonzalez-Scarano
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

3.  Genome analysis of influenza B virus strains isolated during epidemics in boarding schools. Brief report.

Authors:  A M Tikhonova-Heider; A I Klimov; A J Smith; B Grilli; J S Oxford; Y Z Ghendon
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

Review 4.  Monoclonal antibodies against microorganisms.

Authors:  R A Polin
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

5.  Type A influenza (H2N2) viruses isolated in Leningrad in 1980.

Authors:  D B Golubev; G I Karpukhin; S S Galitarov; G M Denisov
Journal:  J Hyg (Lond)       Date:  1985-10

6.  Comparative studies of H3N2 influenza virus strains isolated in May-June, 1982, and in the subsequent epidemic in February, 1983: antigenic and genome analysis.

Authors:  A I Klimov; N A Ivanova; M S Pereira; A M Tikhonova; Y Z Ghendon
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.